TGFB1 and neoplasm: All three mechanisms involve CAFs reducing PCa cell chemosensitivity through paracrine signals (exosomes or secreted proteins), involving metabolic or signaling pathway alterations (TGF-β/GREM2 axis inhibition, ferroptosis suppression, OXPHOS enhancement), allowing tumor cells to adapt to chemotherapy pressure.